Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
PDUFA VII: US FDA Wants Dedicated RMAT Program Funding
Oct 27 2020
•
By
Derrick Gingery
The increased cell and gene therapy workload forced CBER staff to limit sponsor interactions and convert live meetings to "written responses only" status. • Source: Shutterstock
More from User Fees
More from Pathways & Standards